🇺🇸 FDA
Pipeline program

RUC-4 Compound

CEL-01

Phase 1 small_molecule completed

Quick answer

RUC-4 Compound for Coronary Disease is a Phase 1 program (small_molecule) at PRECISION BIOSCIENCES INC with 1 ClinicalTrials.gov record(s).

Program details

Company
PRECISION BIOSCIENCES INC
Indication
Coronary Disease
Phase
Phase 1
Modality
small_molecule
Status
completed

Clinical trials